APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gene Therapy Products Market Outlook and Growth Opportunities 2026

19 December 2025194 pages

Choose your research edition.

Industry ResearchGene Therapy Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy Products Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gene Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy Products Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy Products Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Gene Therapy Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gene Therapy Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gene Therapy Products market include Advantagene, Avalanche Bio, Bluebird Bio, Celladon, Dimension Therapeutics, Sangamo, Spark Therapeutics and Vical Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gene Therapy Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapy Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapy Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gene Therapy Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapy Products Segment by Company

Advantagene

Avalanche Bio

Bluebird Bio

Celladon

Dimension Therapeutics

Sangamo

Spark Therapeutics

Vical Inc.

Gene Therapy Products Segment by Type

Ex vivo

In Vivo

Gene Therapy Products Segment by Application

Cardiovascular disease

Monogenic

Infectious disease

Cancer

Other

Gene Therapy Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gene Therapy Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gene Therapy Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gene Therapy Products significant trends, drivers, influence factors in global and regions.

6. To analyze Gene Therapy Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gene Therapy Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy Products industry.

Chapter 3: Detailed analysis of Gene Therapy Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gene Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gene Therapy Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gene Therapy Products Industry Trends Table 2. Gene Therapy Products Industry Drivers Table 3. Gene Therapy Products Industry Opportunities and Challenges Table 4. Gene Therapy Products Industry Restraints Table 5. Global Gene Therapy Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gene Therapy Products Revenue Share by Company (2021-2026) Table 7. Global Gene Therapy Products Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Gene Therapy Products Sales Volume Share by Company (2021-2026) Table 9. Global Gene Therapy Products Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Gene Therapy Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gene Therapy Products Key Company Manufacturing Base & Headquarters Table 12. Global Gene Therapy Products Company, Product Type & Application Table 13. Global Gene Therapy Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gene Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Ex vivo Table 18. Significant Companies of In Vivo Table 19. Global Gene Therapy Products Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gene Therapy Products Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Gene Therapy Products Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Gene Therapy Products Sales Volume Share by Type (2021-2026) Table 23. Global Gene Therapy Products Sales Volume Share by Type (2027-2032) Table 24. Global Gene Therapy Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gene Therapy Products Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Gene Therapy Products Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Gene Therapy Products Sales Value Share by Type (2021-2026) Table 28. Global Gene Therapy Products Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cardiovascular disease Table 30. Significant Companies of Monogenic Table 31. Significant Companies of Infectious disease Table 32. Significant Companies of Cancer Table 33. Significant Companies of Other Table 34. Global Gene Therapy Products Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Gene Therapy Products Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Gene Therapy Products Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Gene Therapy Products Sales Volume Share by Application (2021-2026) Table 38. Global Gene Therapy Products Sales Volume Share by Application (2027-2032) Table 39. Global Gene Therapy Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Gene Therapy Products Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Gene Therapy Products Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Gene Therapy Products Sales Value Share by Application (2021-2026) Table 43. Global Gene Therapy Products Sales Value Share by Application (2027-2032) Table 44. Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Gene Therapy Products Sales by Region (2021-2026) & (K Units) Table 46. Global Gene Therapy Products Sales Market Share by Region (2021-2026) Table 47. Global Gene Therapy Products Sales by Region (2027-2032) & (K Units) Table 48. Global Gene Therapy Products Sales Market Share by Region (2027-2032) Table 49. Global Gene Therapy Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Gene Therapy Products Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Gene Therapy Products Sales Value Share by Region (2021-2026) Table 52. Global Gene Therapy Products Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Gene Therapy Products Sales Value Share by Region (2027-2032) Table 54. Global Gene Therapy Products Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Gene Therapy Products Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Gene Therapy Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 59. Global Gene Therapy Products Sales Market Share by Country (2021-2026) Table 60. Global Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 61. Global Gene Therapy Products Sales Market Share by Country (2027-2032) Table 62. Global Gene Therapy Products Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Gene Therapy Products Sales Value Market Share by Country (2021-2026) Table 64. Global Gene Therapy Products Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Gene Therapy Products Sales Value Market Share by Country (2027-2032) Table 66. Advantagene Company Information Table 67. Advantagene Business Overview Table 68. Advantagene Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Advantagene Gene Therapy Products Product Portfolio Table 70. Advantagene Recent Development Table 71. Avalanche Bio Company Information Table 72. Avalanche Bio Business Overview Table 73. Avalanche Bio Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Avalanche Bio Gene Therapy Products Product Portfolio Table 75. Avalanche Bio Recent Development Table 76. Bluebird Bio Company Information Table 77. Bluebird Bio Business Overview Table 78. Bluebird Bio Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bluebird Bio Gene Therapy Products Product Portfolio Table 80. Bluebird Bio Recent Development Table 81. Celladon Company Information Table 82. Celladon Business Overview Table 83. Celladon Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Celladon Gene Therapy Products Product Portfolio Table 85. Celladon Recent Development Table 86. Dimension Therapeutics Company Information Table 87. Dimension Therapeutics Business Overview Table 88. Dimension Therapeutics Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Dimension Therapeutics Gene Therapy Products Product Portfolio Table 90. Dimension Therapeutics Recent Development Table 91. Sangamo Company Information Table 92. Sangamo Business Overview Table 93. Sangamo Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sangamo Gene Therapy Products Product Portfolio Table 95. Sangamo Recent Development Table 96. Spark Therapeutics Company Information Table 97. Spark Therapeutics Business Overview Table 98. Spark Therapeutics Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Spark Therapeutics Gene Therapy Products Product Portfolio Table 100. Spark Therapeutics Recent Development Table 101. Vical Inc. Company Information Table 102. Vical Inc. Business Overview Table 103. Vical Inc. Gene Therapy Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Vical Inc. Gene Therapy Products Product Portfolio Table 105. Vical Inc. Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Gene Therapy Products Distributors List Table 109. Gene Therapy Products Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Gene Therapy Products Product Image Figure 2. Global Gene Therapy Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Therapy Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gene Therapy Products Sales (2021-2032) & (K Units) Figure 5. Global Gene Therapy Products Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Gene Therapy Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Ex vivo Image Figure 10. In Vivo Image Figure 11. Global Gene Therapy Products Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Gene Therapy Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Gene Therapy Products Sales Volume Share by Type (2021-2032) Figure 14. Global Gene Therapy Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Gene Therapy Products Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Gene Therapy Products Sales Value Share by Type (2021-2032) Figure 17. Cardiovascular disease Image Figure 18. Monogenic Image Figure 19. Infectious disease Image Figure 20. Cancer Image Figure 21. Other Image Figure 22. Global Gene Therapy Products Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Gene Therapy Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Gene Therapy Products Sales Volume Share by Application (2021-2032) Figure 25. Global Gene Therapy Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Gene Therapy Products Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Gene Therapy Products Sales Value Share by Application (2021-2032) Figure 28. Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Gene Therapy Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Gene Therapy Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Gene Therapy Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Gene Therapy Products Sales Value (2021-2032) & (US$ Million) Figure 33. North America Gene Therapy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Gene Therapy Products Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Gene Therapy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Gene Therapy Products Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Gene Therapy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Gene Therapy Products Sales Value (2021-2032) & (US$ Million) Figure 39. South America Gene Therapy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Gene Therapy Products Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Gene Therapy Products Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Gene Therapy Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Gene Therapy Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Gene Therapy Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Gene Therapy Products Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Gene Therapy Products Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Ex vivo
  • In Vivo
Applications
  • Cardiovascular disease
  • Monogenic
  • Infectious disease
  • Cancer
  • Other
Companies covered
  • Advantagene
  • Avalanche Bio
  • Bluebird Bio
  • Celladon
  • Dimension Therapeutics
  • Sangamo
  • Spark Therapeutics
  • Vical Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gene Therapy Products Sales Value (2021-2032)
  4. 1.2.2 Global Gene Therapy Products Sales Volume (2021-2032)
  5. 1.2.3 Global Gene Therapy Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gene Therapy Products Market Dynamics
  1. 2.1 Gene Therapy Products Industry Trends
  2. 2.2 Gene Therapy Products Industry Drivers
  3. 2.3 Gene Therapy Products Industry Opportunities and Challenges
  4. 2.4 Gene Therapy Products Industry Restraints
3 Gene Therapy Products Market by Company
  1. 3.1 Global Gene Therapy Products Company Revenue Ranking in 2025
  2. 3.2 Global Gene Therapy Products Revenue by Company (2021-2026)
  3. 3.3 Global Gene Therapy Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Gene Therapy Products Average Price by Company (2021-2026)
  5. 3.5 Global Gene Therapy Products Company Ranking (2024-2026)
  6. 3.6 Global Gene Therapy Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Gene Therapy Products Company Product Type and Application
  8. 3.8 Global Gene Therapy Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gene Therapy Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gene Therapy Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gene Therapy Products Market by Type
  1. 4.1 Gene Therapy Products Type Introduction
  2. 4.1.1 Ex vivo
  3. 4.1.2 In Vivo
  4. 4.2 Global Gene Therapy Products Sales Volume by Type
  5. 4.2.1 Global Gene Therapy Products Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Gene Therapy Products Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Gene Therapy Products Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Gene Therapy Products Sales Value by Type
  9. 4.3.1 Global Gene Therapy Products Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Gene Therapy Products Sales Value by Type (2021-2032)
  11. 4.3.3 Global Gene Therapy Products Sales Value Share by Type (2021-2032)
5 Gene Therapy Products Market by Application
  1. 5.1 Gene Therapy Products Application Introduction
  2. 5.1.1 Cardiovascular disease
  3. 5.1.2 Monogenic
  4. 5.1.3 Infectious disease
  5. 5.1.4 Cancer
  6. 5.1.5 Other
  7. 5.2 Global Gene Therapy Products Sales Volume by Application
  8. 5.2.1 Global Gene Therapy Products Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Gene Therapy Products Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Gene Therapy Products Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Gene Therapy Products Sales Value by Application
  12. 5.3.1 Global Gene Therapy Products Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Gene Therapy Products Sales Value by Application (2021-2032)
  14. 5.3.3 Global Gene Therapy Products Sales Value Share by Application (2021-2032)
6 Gene Therapy Products Regional Sales and Value Analysis
  1. 6.1 Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gene Therapy Products Sales by Region (2021-2032)
  3. 6.2.1 Global Gene Therapy Products Sales by Region: 2021-2026
  4. 6.2.2 Global Gene Therapy Products Sales by Region (2027-2032)
  5. 6.3 Global Gene Therapy Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gene Therapy Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gene Therapy Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gene Therapy Products Sales Value by Region (2027-2032)
  9. 6.5 Global Gene Therapy Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gene Therapy Products Sales Value (2021-2032)
  12. 6.6.2 North America Gene Therapy Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gene Therapy Products Sales Value (2021-2032)
  15. 6.7.2 Europe Gene Therapy Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gene Therapy Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gene Therapy Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gene Therapy Products Sales Value (2021-2032)
  21. 6.9.2 South America Gene Therapy Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gene Therapy Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gene Therapy Products Sales Value Share by Country, 2025 VS 2032
7 Gene Therapy Products Country-level Sales and Value Analysis
  1. 7.1 Global Gene Therapy Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gene Therapy Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gene Therapy Products Sales by Country (2021-2032)
  4. 7.3.1 Global Gene Therapy Products Sales by Country (2021-2026)
  5. 7.3.2 Global Gene Therapy Products Sales by Country (2027-2032)
  6. 7.4 Global Gene Therapy Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gene Therapy Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gene Therapy Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gene Therapy Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gene Therapy Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gene Therapy Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gene Therapy Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gene Therapy Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gene Therapy Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gene Therapy Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gene Therapy Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gene Therapy Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gene Therapy Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gene Therapy Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gene Therapy Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gene Therapy Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gene Therapy Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gene Therapy Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gene Therapy Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gene Therapy Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gene Therapy Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gene Therapy Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gene Therapy Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gene Therapy Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gene Therapy Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gene Therapy Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gene Therapy Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gene Therapy Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gene Therapy Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gene Therapy Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gene Therapy Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gene Therapy Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gene Therapy Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Advantagene
  2. 8.1.1 Advantagene Company Information
  3. 8.1.2 Advantagene Business Overview
  4. 8.1.3 Advantagene Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Advantagene Gene Therapy Products Product Portfolio
  6. 8.1.5 Advantagene Recent Developments
  7. 8.2 Avalanche Bio
  8. 8.2.1 Avalanche Bio Company Information
  9. 8.2.2 Avalanche Bio Business Overview
  10. 8.2.3 Avalanche Bio Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Avalanche Bio Gene Therapy Products Product Portfolio
  12. 8.2.5 Avalanche Bio Recent Developments
  13. 8.3 Bluebird Bio
  14. 8.3.1 Bluebird Bio Company Information
  15. 8.3.2 Bluebird Bio Business Overview
  16. 8.3.3 Bluebird Bio Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bluebird Bio Gene Therapy Products Product Portfolio
  18. 8.3.5 Bluebird Bio Recent Developments
  19. 8.4 Celladon
  20. 8.4.1 Celladon Company Information
  21. 8.4.2 Celladon Business Overview
  22. 8.4.3 Celladon Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Celladon Gene Therapy Products Product Portfolio
  24. 8.4.5 Celladon Recent Developments
  25. 8.5 Dimension Therapeutics
  26. 8.5.1 Dimension Therapeutics Company Information
  27. 8.5.2 Dimension Therapeutics Business Overview
  28. 8.5.3 Dimension Therapeutics Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dimension Therapeutics Gene Therapy Products Product Portfolio
  30. 8.5.5 Dimension Therapeutics Recent Developments
  31. 8.6 Sangamo
  32. 8.6.1 Sangamo Company Information
  33. 8.6.2 Sangamo Business Overview
  34. 8.6.3 Sangamo Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sangamo Gene Therapy Products Product Portfolio
  36. 8.6.5 Sangamo Recent Developments
  37. 8.7 Spark Therapeutics
  38. 8.7.1 Spark Therapeutics Company Information
  39. 8.7.2 Spark Therapeutics Business Overview
  40. 8.7.3 Spark Therapeutics Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Spark Therapeutics Gene Therapy Products Product Portfolio
  42. 8.7.5 Spark Therapeutics Recent Developments
  43. 8.8 Vical Inc.
  44. 8.8.1 Vical Inc. Company Information
  45. 8.8.2 Vical Inc. Business Overview
  46. 8.8.3 Vical Inc. Gene Therapy Products Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vical Inc. Gene Therapy Products Product Portfolio
  48. 8.8.5 Vical Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gene Therapy Products Value Chain Analysis
  2. 9.1.1 Gene Therapy Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gene Therapy Products Sales Mode & Process
  6. 9.2 Gene Therapy Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gene Therapy Products Distributors
  9. 9.2.3 Gene Therapy Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst